keratitis

Search with Google Search with Bing
Information
Disease name
keratitis
Disease ID
DOID:4677
Description
"A corneal disease that is characterized by inflammation of the cornea." [url:http\://www.mayoclinic.org/diseases-conditions/keratitis/basics/definition/con-20035288]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00001648 Completed Structure of the Herpes Simplex Virus Receptor August 20, 1997 April 13, 2010
NCT00001734 Completed Screening for NEI Clinical Studies March 23, 1998 October 3, 2008
NCT00008541 Completed Evaluation and Treatment of Patients With Corneal and External Diseases January 2, 2001 March 6, 2009
NCT00949468 Completed Microbiological Keratitis in a Countryside City of Brazil June 2008 July 2009
NCT01028027 Completed Phase 3 Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis October 2009 March 2010
NCT01268306 Completed Phase 4 Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses October 2010 December 2010
NCT01272271 Completed Safety of Overnight Corneal Reshaping Lenses February 2008 October 2010
NCT01756456 Completed Phase 1/Phase 2 Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. January 2013 May 2016
NCT01794312 Completed Phase 3 Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer February 2013 December 19, 2017
NCT02151305 Completed N/A Different Hemostasis According to the Anesthetic Agents August 2010 April 2012
NCT02186431 Completed N/A Contact Lenses and Infiltrative Keratitis July 2014 May 2016
NCT02293876 Completed N/A Corneal Lesions in Intensive Care Unit (ICU) Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center Clinical Trial for Proposing Interventions and Evaluating Outcomes of Nursing in the Adult Intensive Care Center April 2013 November 2014
NCT03237936 Completed Phase 4 Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis March 28, 2017 July 11, 2018
NCT03586505 Completed N/A Tolerance to Light for Patients Suffering From Keratitis July 3, 2018 August 7, 2019
NCT03706443 Completed N/A Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops December 5, 2018 February 28, 2019
NCT04169061 Completed Phase 4 Impact of Acthar on Everyday Life of Participants With Severe Keratitis November 13, 2019 December 7, 2020
NCT05538793 Completed Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study July 1, 2020 October 20, 2023
NCT06070883 Completed N/A Efficacy of Mutilayered Fresh Amnoitic Membrane Transplantation in Resistant Fungal Keratitis January 1, 2022 October 1, 2023
NCT00513734 Completed N/A A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill September 2004 February 2005
NCT00732446 Completed Phase 3 Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis August 2008 February 2009
NCT05689996 Not yet recruiting Phase 3 Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis January 2023 May 1, 2023
NCT04420962 Recruiting Automated Quantitative Ulcer Analysis Study July 23, 2020 July 2024
NCT05183906 Recruiting Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis December 9, 2021 June 1, 2024
NCT05255016 Recruiting Phase 2/Phase 3 Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers March 14, 2022 February 24, 2024
NCT06229379 Recruiting N/A The Effects of a Large Language Model on Clinical Questioning Skills September 1, 2023 June 2024
NCT05255107 Recruiting Phase 2/Phase 3 Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers March 14, 2022 February 24, 2024
NCT05432336 Recruiting Complex Ocular Infection, Optimization of Microbiological Diagnosis November 21, 2023 May 2025
NCT05250583 Terminated Phase 2 Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis June 29, 2020 January 7, 2021
NCT02116062 Terminated N/A Robotic Surgery of the Ocular Surface June 2014 April 2018
NCT04075669 Unknown status Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples August 1, 2019 June 2020
NCT02865876 Unknown status Phase 3 Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis June 2015 March 2017
NCT00838422 Unknown status Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound June 2008 June 2009
NCT03436576 Unknown status Phase 3 Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye September 12, 2018 November 19, 2018
NCT00492245 Unknown status N/A Phototherapeutic Keratectomy (PTK) With Mitomycin in Adenoviral Opacities April 2006 December 2008
NCT01721694 Withdrawn Phase 3 Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection December 2012 May 2013
Disase is a (Disease Ontology)
DOID:10124
Cross Reference ID (Disease Ontology)
ICD10CM:H16
Cross Reference ID (Disease Ontology)
ICD9CM:370
Cross Reference ID (Disease Ontology)
MESH:D007634
Cross Reference ID (Disease Ontology)
NCI:C26805
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:193757003
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0022568
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0000491
ICD10 preferred id (Insert disease from ICD10)
D0006059
ICD10 class code (Insert disease from ICD10)
H16
MeSH unique ID (MeSH (Medical Subject Headings))
D007634